Browsing Tag
Jideytro
1 post
GSK specialty medicines sales rise 15% as £328m restructuring charge weakens reported profit
GSK reported £8.89 billion in third-quarter sales as specialty medicines expanded strongly across HIV, respiratory diseases and oncology. However, vaccines remained weak and a £328 million restructuring charge contributed to lower statutory earnings, while management maintained its 2026 and 2031 growth targets.